|
LIN9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.960800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.689600E-01 |
| Normal-vs-Stage2 |
4.417400E-01 |
| Normal-vs-Stage3 |
6.727800E-01 |
| Normal-vs-Stage4 |
8.859200E-01 |
| Stage1-vs-Stage2 |
7.829600E-01 |
| Stage1-vs-Stage3 |
1.437980E-01 |
| Stage1-vs-Stage4 |
5.049000E-01 |
| Stage2-vs-Stage3 |
2.828600E-01 |
| Stage2-vs-Stage4 |
5.050600E-01 |
| Stage3-vs-Stage4 |
5.608800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.640400E-01 |
| Normal-vs-AfricanAmerican |
2.429700E-02 |
| Normal-vs-Asian |
2.571600E-01 |
| Caucasian-vs-AfricanAmerican |
4.187100E-04 |
| Caucasian-vs-Asian |
5.118800E-01 |
| AfricanAmerican-vs-Asian |
2.670400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.395800E-01 |
| Normal-vs-Female |
9.866000E-01 |
| Male-vs-Female |
3.690400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.523800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.286400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.063600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.211800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.618400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.958600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.436630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.532800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.729800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.493040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.945800E-01 |
| Normal-vs-Grade 2 |
9.332400E-02 |
| Normal-vs-Grade 3 |
6.002200E-01 |
| Normal-vs-Grade 4 |
5.084600E-01 |
| Grade 1-vs-Grade 2 |
8.785400E-01 |
| Grade 1-vs-Grade 3 |
2.909600E-01 |
| Grade 1-vs-Grade 4 |
3.980400E-01 |
| Grade 2-vs-Grade 3 |
5.395700E-03 |
| Grade 2-vs-Grade 4 |
4.426400E-02 |
| Grade 3-vs-Grade 4 |
7.070800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.445600E-02 |
| Normal-vs-ccB subtype |
6.022400E-01 |
| ccA subtype-vs-ccB subtype |
1.364270E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.272600E-01 |
| Normal-vs-N1 |
4.832600E-01 |
| N0-vs-N1 |
7.417200E-01 |
|
|
